On the behalf of Fondazione Italiana Linfomi (FIL), Alessandria, Italy, | S. Orsola-Malpighi Hematology-Oncology, University of Bologna, Bologna, Italy, | Department of ...
KOL Resume for Luigi Gugliotta
On the behalf of Fondazione Italiana Linfomi (FIL), Alessandria, Italy,
S. Orsola-Malpighi Hematology-Oncology, University of Bologna, Bologna, Italy,
Department of Hematology, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy,
Ematologia-Reggio Emilia, Italy
Division of Hematology, Reggio Emilia, Italy
Hematology, Hosp.S.Maria Nuova, Reggio Emilia, Italy
Prominent publications by Luigi Gugliotta
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis o
[ PUBLICATION ]
BACKGROUND: The phase 3 GIMEMA-MMY-3006 trial, which compared bortezomib, thalidomide, and dexamethasone (VTD) combination therapy with thalidomide and dexamethasone (TD) as induction therapy before and consolidation therapy after double autologous haematopoietic stem-cell transplantation (HSCT) for newly diagnosed multiple myeloma, showed the superiority of the triplet regimen over the doublet in terms of increased complete response rate and improved progression-free survival. We report ...
|Known for Multiple Myeloma | Cell Transplantation | Induction Therapy | Triplet Regimen | Bortezomib Dexamethasone|
Key People For Essential Thrombocythemia
Luigi Gugliotta:Expert Impact
Concepts for whichLuigi Gugliottahas direct influence:Essential thrombocythemia, Rituximab patients, Rituximab itp, Imatinib therapy, Patients itp, Diagnosed multiple, Primary immune thrombocytopenia, Itp patients.
Luigi Gugliotta:KOL impact
Concepts related to the work of other authors for whichfor which Luigi Gugliotta has influence:Multiple myeloma, Immune thrombocytopenia, Postprotocol therapies, Eosinophilic disorders, Minimal residual disease, Patients rituximab, Idecabtagene vicleucel.
Is this your profile? Claim your profile Copy URL Embed Link to your profile